Healthpeak Properties (DOC) Stock Forecast & Price Target

$21.42 +0.03 (+0.14%)

(As of 11/20/2024 ET)

Healthpeak Properties - Analysts' Recommendations and Stock Price Forecast (2024)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Moderate Buy

Based on 16 Analyst Ratings

Sell
0

Hold
5

Buy
11

Based on 16 Wall Street analysts who have issued ratings for Healthpeak Properties in the last 12 months, the stock has a consensus rating of "Moderate Buy." Out of the 16 analysts, 5 have given a hold rating, 10 have given a buy rating, and 1 has given a strong buy rating for DOC.

Consensus Price Target

$22.86
6.68% Upside

According to the 16 analysts' twelve-month price targets for Healthpeak Properties, the average price target is $22.86. The highest price target for DOC is $28.00, while the lowest price target for DOC is $14.00. The average price target represents a forecasted upside of 6.68% from the current price of $21.43.

Get the Latest News and Ratings for DOC and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Healthpeak Properties and its competitors.

DOC Analyst Ratings Over Time

Type	Current Forecast 11/22/23 to 11/21/24	1 Month Ago 10/23/23 to 10/22/24	3 Months Ago 8/24/23 to 8/23/24	1 Year Ago 11/22/22 to 11/22/23
Strong Buy	1 Strong Buy rating(s)	1 Strong Buy rating(s)	2 Strong Buy rating(s)	0 Strong Buy rating(s)
Buy	10 Buy rating(s)	9 Buy rating(s)	7 Buy rating(s)	3 Buy rating(s)
Hold	5 Hold rating(s)	5 Hold rating(s)	5 Hold rating(s)	5 Hold rating(s)
Sell	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)	1 Sell rating(s)
Consensus Price Target	$22.86	$22.62	$21.36	$15.70
Forecasted Upside	6.68% Upside	0.83% Upside	-4.88% Downside	39.37% Upside
Consensus Rating	Moderate Buy	Moderate Buy	Moderate Buy	Hold

This Bull Market Indicator called NVDA at $116 (Ad)

Every now and again we find an investment idea so incredible we can’t help but share. And today is one of those rare days… Except, today we won't be giving you insight on any one particular stock… But rather, insight on a revolutionary new stock picking indicator… In fact, within the last year, this indicator has become famous for a multitude of reasons… But one of the biggest was because of the buy signal it issued on October 18th, 2022. In fact, on that very day, it said to buy NVDA at $116.37… Anyone who did would be sitting on a tremendously large return today… But even if you missed the original buy signal from October, this incredible indicator issued 11 other buy signals while Nvidia made its epic run…

All you have to do is follow this link here

DOC Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

DOC Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

Healthpeak Properties Stock vs. The Competition

Type	Healthpeak Properties	Finance Companies	S&P 500
Consensus Rating Score	2.75	2.49	2.50
Consensus Rating	Moderate Buy	Hold	Moderate Buy
Predicted Upside	6.68% Upside	12.88% Upside	9.81% Upside
News Sentiment Rating	Very Positive News See Recent DOC News	Positive News	Positive News

Recent Analyst Forecasts and Stock Ratings

Rating

Upside/Downside

Action

Time Frame

Start Date

End Date

Show

Export to Excel

Date	Brokerage	Analyst Name	Action	Rating	Price Target	Upside/Downside on Report Date
11/4/2024	Royal Bank of Canada 4 of 5 stars		Boost Target	Outperform ➝ Outperform	$25.00 ➝ $26.00	+17.75%
10/30/2024	Robert W. Baird 2 of 5 stars		Boost Target	Outperform ➝ Outperform	$24.00 ➝ $25.00	+10.99%
10/21/2024	Deutsche Bank Aktiengesellschaft 3 of 5 stars		Upgrade	Hold ➝ Buy	$20.00 ➝ $28.00	+23.67%
10/1/2024	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating	J. Feldman Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Equal Weight ➝ Equal Weight	$22.00 ➝ $23.00	+2.04%
9/16/2024	Evercore ISI Subscribe to MarketBeat All Access for the recommendation accuracy rating	J. Kammert Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Target	Outperform ➝ Outperform	$25.00 ➝ $26.00	+15.66%
9/9/2024	Scotiabank Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Sector Outperform ➝ Sector Outperform	$23.00 ➝ $24.00	+8.79%
Get the Latest News and Ratings for DOC and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Healthpeak Properties and its competitors with MarketBeat's FREE daily newsletter.
8/22/2024	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Neutral ➝ Neutral	$20.00 ➝ $22.00	-0.23%
7/29/2024	Wedbush Subscribe to MarketBeat All Access for the recommendation accuracy rating	R. Anderson Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Target	Outperform ➝ Outperform	$22.00 ➝ $25.00	+14.16%
5/16/2024	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Neutral ➝ Neutral	$19.00 ➝ $21.00	+3.70%
5/9/2024	Argus Subscribe to MarketBeat All Access for the recommendation accuracy rating	M. Ferguson Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Strong-Buy
4/26/2024	BNP Paribas Subscribe to MarketBeat All Access for the recommendation accuracy rating		Upgrade	Neutral ➝ Outperform	$19.00 ➝ $21.00	+11.94%
4/22/2024	Mizuho Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated Rating	Buy	$22.00	+22.36%
4/1/2024	Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating		Upgrade	Underperform ➝ Buy	$18.00 ➝ $25.00	+33.33%
1/5/2024	KeyCorp Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated Rating	Overweight ➝ Sector Weight
1/2/2024	Compass Point Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Buy ➝ Buy	$19.00 ➝ $18.00	+35.75%
12/22/2023	Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Hold ➝ Hold	$15.00 ➝ $14.00	+5.74%
7/20/2023	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated Rating	Equal Weight ➝ Equal Weight	$14.50	-1.16%
5/26/2023	JMP Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating		Initiated Coverage	Outperform	$15.50	+14.81%
5/5/2023	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target		$18.00 ➝ $17.00	+17.73%
3/29/2023	Credit Suisse Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated Rating	Neutral	$15.00	+2.88%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Thursday at 05:25 AM ET.

DOC Forecast - Frequently Asked Questions

: According to the research reports of 16 Wall Street equities research analysts, the average twelve-month stock price forecast for Healthpeak Properties is $22.86, with a high forecast of $28.00 and a low forecast of $14.00.
: 16 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Healthpeak Properties in the last year. There are currently 5 hold ratings, 10 buy ratings and 1 strong buy rating for the stock. The consensus among Wall Street research analysts is that investors should "moderate buy" DOC shares.
: According to analysts, Healthpeak Properties's stock has a predicted upside of 6.68% based on their 12-month stock forecasts.
: Over the previous 90 days, Healthpeak Properties's stock had 1 upgrade by analysts.
: Healthpeak Properties has been rated by research analysts at Deutsche Bank Aktiengesellschaft, Evercore ISI, Robert W. Baird, Royal Bank of Canada, Scotiabank, and Wells Fargo & Company in the past 90 days.
: Analysts like Healthpeak Properties more than other "finance" companies. The consensus rating for Healthpeak Properties is Moderate Buy while the average consensus rating for "finance" companies is Hold. Learn more on how DOC compares to other companies.

Stock Forecasts and Research Tools

Related Companies

Today's Ratings

Top Rated Stocks

More Ratings Tools

Tesla Execs are Freaking Out (Ad)

It’s so revolutionary that tech giants like Microsoft, Amazon, and NVIDIA are all lining up to get their hands on it. And Elon Musk has completely restructured Tesla to chase this opportunity. This is a once-in-a-lifetime opportunity that you don’t want to miss.

Click here to get the details.

This page (NYSE:DOC) was last updated on 11/21/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Healthpeak Properties (DOC) Stock Forecast & Price Target